Proton Pump Inhibitors and Gastric Cancer
Concerns have been raised regarding the long-term use of proton pump inhibitors (PPIs) as an important risk factor for gastric cancer in clinical practice. PPIs can cause hypergastrinemia at clinical doses, and hypergastrinemia has been reported to induce malignant neoplasms in the stomach in previo...
Saved in:
Main Authors: | Seungkyung Kang, Soo-Jeong Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2021-09-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2021-0010.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastric Corpus Hypertrophy with a Bleeding Hyperplastic Polyp in a -naive Subject after Long-term Proton Pump Inhibitor Use
by: Jong Hyeon Jeong, et al.
Published: (2022-03-01) -
Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01) -
Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
by: Tae Jun Kim, et al.
Published: (2020-09-01) -
Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis
by: Kyu-Tae Yoon, et al.
Published: (2021-06-01) -
Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors
by: Maxwell Rossip, et al.
Published: (2025-06-01)